帕金森症Synaptojanin-1中的Sac域突变会影响iPSC衍生的多巴胺基神经元中的状物质
Nisha Mohd Rafiq1,2,3,4, Kenshiro Fujise1,2,3,4, Martin Shaun Rosenfeld1,2,3,4
1Department of Neuroscience, Yale University School of Medicine, New Haven, CT 06510.
概括
赛纳普托亚宁-1 (SJ1) 功能障碍会损害多巴胺神经元的功能,并导致毛的异常生长. 这表明SJ1对于乳毛中的蛋白质清除至关重要,影响这些重要神经元的信号传递.
科学领域:
- 神经科学是一个神经科学.
- 细胞生物学 细胞生物学
- 生物化学 生物化学
背景情况:
- 赛纳普托宁-1 (SJ1) 是细胞内的关键酶,调节酸丁酸 (4,5) - 双酸盐水平.
- 一种特定的突变 (R258Q) 损害了SJ1的4-酸酶活性,导致帕金森症和神经系统缺陷.
研究的目的:
- 研究SJ1功能障碍对多巴胺 (DA) 神经元的特定影响.
- 探索SJ1在神经和蛋白质动态中的作用.
主要方法:
- 利用来自SJ1淘汰赛 (KO) 和SJ1 R258Q淘汰赛 (RQ KI) 模型的诱导多能干细胞 (iPSC) 衍生的DA神经元.
- 分析了内细胞因子聚类,乳毛长度和乳毛底部的蛋白质积累.
主要成果:
- 缺少SJ1的DA神经元表现出增强的内细胞因子聚类和显著增加的毛长度.
- 在SJ1 RQ DA神经元的底部观察到CaV1.3通道和泛素链的积累.
- 发现SJ1的焦点集中在纤毛底部,这表明它在蛋白质清除中起着作用.
结论:
- SJ1在调节神经内蛋白质动态方面发挥着关键作用,特别是在DA神经元中.
- 功能受损的SJ1可能会导致在底部清除无化蛋白质的缺陷.
- 这些发现表明,在DA神经元功能和神经退行性疾病 (如帕金森症) 中,纤毛介导的信号传递有意义.
更多相关视频
09:21Author Spotlight: Generating Neuronal Phenotypic Profiles - A Protocol to Culture and Image Human Midbrain Dopaminergic Neurons
Published on: July 7, 2023
1.5K
12:13Generation of Induced Neural Stem Cells from Peripheral Mononuclear Cells and Differentiation Toward Dopaminergic Neuron Precursors for Transplantation Studies
Published on: July 11, 2019
7.2K
相关概念视频
Parkinson's Disease: Overview
541
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
541
Neural Regulation
39.4K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.4K
EPS and iPS Cells in Disease Research
2.8K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.8K
Parkinson's Disease: Treatment
264
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
264
iPS Cell Differentiation
2.7K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.7K
